<a href="https://laohu8.com/S/00897">Wai Yuen Tong</a> Medicine Holdings revenue falls 6.9% with profit down 88.2%
Wai Yuen Tong Medicine Holdings Limited reported revenue of HK$322.8 million for the six months ended 30 September 2025, a decrease of 6.9% compared to HK$346.8 million in the same period last year. Gross profit declined by 9.2% to HK$165.3 million. Profit attributable to owners of the parent fell 88.2% to HK$2.8 million. Basic and diluted earnings per share were 0.25 HK cents, compared to 2.10 HK cents previously. As of 30 September 2025, the Group's net asset value was HK$1,181.5 million and cash and cash equivalents stood at HK$121.2 million. The principal activities during the period included the production and sale of Chinese pharmaceutical and health food products, provision of Traditional Chinese Medicine services, and management and promotion services, mainly in Mainland China and Hong Kong.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wai Yuen Tong Medicine Holdings Limited published the original content used to generate this news brief via via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251124-11926696), on November 24, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。